🇺🇸 FDA

Drug profile · INN

coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)

COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL

Patents linked
0
News articles
0

Quick answer

coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)
Brand COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL

Frequently asked questions

What is coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)?

coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)?

COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran). Check FDA Drugs@FDA for the current US label holder and prescribing information.